Literature DB >> 870427

Intestinal fluid accumulation induced by oral challenge with Vibrio cholerae or cholera toxin in infant mice.

V Baselski, R Briggs, C Parker.   

Abstract

The diarrheal response of orally inoculated infant mice to viable Vibrio cholerae and purified cholera toxin was quantitated by means of a fluid accumulation (FA) ratio. The FA ratio is defined as the gut weight/remaining body weight. FA ratios were determined in relation to time of exposure and dose. Onset of fluid accumulation with viable cells of strains CA401 and 569B occurred 8 h postinoculation and reached a near maximum of 16 h. A dose of 4 x 10(6) colony-forming units of strain CA401 was required for a positive response 16 to 18 h postinoculation. Several other classical cholera strains demonstrated a similar dose-related response. Strain 569B, however, required a 100-fold higher dose to give a positive response. Several mutant cholera strains were decreased virulence in other model systems elicited FA ratios decreased from wild-type values. Onset of fluid accumulation which cholera toxin occurred 6 to 8 h postinoculation and reached a maximum by 10 h. A dose of 0.5 microng was required for a positive response 10 to 12 h postinoculation. The positive response to toxin could be inhibited by preincubation with specific antitoxin.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 870427      PMCID: PMC421427          DOI: 10.1128/iai.15.3.704-712.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  24 in total

1.  PATHOGENESIS EXPERIMENTAL CHOLERA IN INFANT RABBITS. I. OBSERVATIONS ON THE INTRAINTESTINAL INFECTION AND EXPERIMENTAL CHOLERA PRODUCED WITH CELL-FREE PRODUCTS.

Authors:  R A FINKELSTEIN; H T NORRIS; N K DUTTA
Journal:  J Infect Dis       Date:  1964-06       Impact factor: 5.226

2.  Experimental cholera in infant rabbits: a method for chemotherapeutic investigation.

Authors:  N K DUTTA; M K HABBU
Journal:  Br J Pharmacol Chemother       Date:  1955-06

3.  Vibrio cholerae infection in the embryonated egg.

Authors:  E W GARDNER; S T LYLES; C E LANKFORD; S J HAGENS
Journal:  J Infect Dis       Date:  1963 May-Jun       Impact factor: 5.226

4.  Enterotoxicity of bacteria-free culture-filtrate of Vibrio cholerae.

Authors:  S N DE
Journal:  Nature       Date:  1959-05-30       Impact factor: 49.962

5.  Role of cholera a toxin in experimental cholera.

Authors:  N K DUTTA; M V PANSE; D R KULKARNI
Journal:  J Bacteriol       Date:  1959-10       Impact factor: 3.490

6.  An experimental study of the mechanism of action of Vibriod cholerae on the intestinal mucous membrane.

Authors:  S N DE; D N CHATTERJE
Journal:  J Pathol Bacteriol       Date:  1953-10

7.  Studies on toxinogenesis in Vibrio cholerae. I. Isolation of mutants with altered toxinogenicity.

Authors:  R A Finkelstein; M L Vasil; R K Holmes
Journal:  J Infect Dis       Date:  1974-02       Impact factor: 5.226

8.  Intestinal adenyl-cyclase activity in canine cholera: correlation with fluid accumulation.

Authors:  R L Guerrant; L C Chen; G W Sharp
Journal:  J Infect Dis       Date:  1972-04       Impact factor: 5.226

9.  Differences in the response of rabbit small intestine to heat-labile and heat-stable enterotoxins of Escherichia coli.

Authors:  D G Evans; D J Evans; N F Pierce
Journal:  Infect Immun       Date:  1973-06       Impact factor: 3.441

10.  Biochemical properties of Escherichia coli low-molecular-weight, heat-stable enterotoxin.

Authors:  T M Jacks; B J Wu
Journal:  Infect Immun       Date:  1974-02       Impact factor: 3.441

View more
  47 in total

1.  The Vibrio cholerae vieSAB locus encodes a pathway contributing to cholera toxin production.

Authors:  Anna D Tischler; Sang Ho Lee; Andrew Camilli
Journal:  J Bacteriol       Date:  2002-08       Impact factor: 3.490

2.  Upregulation of virulence genes promotes Vibrio cholerae biofilm hyperinfectivity.

Authors:  A L Gallego-Hernandez; W H DePas; J H Park; J K Teschler; R Hartmann; H Jeckel; K Drescher; S Beyhan; D K Newman; F H Yildiz
Journal:  Proc Natl Acad Sci U S A       Date:  2020-04-30       Impact factor: 11.205

3.  Purification and characterization of a cytotonic protein expressed In vitro by the live cholera vaccine candidate CVD 103-HgR.

Authors:  V Sathyamoorthy; R H Hall; B A McCardell; M H Kothary; S J Ahn; S Ratnayake
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

4.  In vivo and in vitro characterization of virulence-deficient mutants of Vibrio cholerae.

Authors:  V S Baselski; R A Medina; C D Parker
Journal:  Infect Immun       Date:  1979-04       Impact factor: 3.441

5.  The OmpU outer membrane protein, a potential adherence factor of Vibrio cholerae.

Authors:  V Sperandio; J A Girón; W D Silveira; J B Kaper
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

6.  Ability of an avirulent mutant of Vibrio cholerae to colonize in the infant mouse upper bowel.

Authors:  S P Sigel; R A Finkelstein; C D Parker
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.441

7.  Protection against Vibrio cholerae El Tor infection by specific antibodies against mannose-binding hemagglutinin pili.

Authors:  J Osek; A M Svennerholm; J Holmgren
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

8.  Vibrio factors cause rapid fluid accumulation in suckling mice.

Authors:  M Nishibuchi; R J Seidler; D M Rollins; S W Joseph
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

9.  Medium-dependent production of extracellular enterotoxins by non-O-1 Vibrio cholerae, Vibrio mimicus, and Vibrio fluvialis.

Authors:  M Nishibuchi; R J Seidler
Journal:  Appl Environ Microbiol       Date:  1983-01       Impact factor: 4.792

10.  Intestinal adherence of Vibrio cholerae involves a coordinated interaction between colonization factor GbpA and mucin.

Authors:  Rudra Bhowmick; Abhisek Ghosal; Bhabatosh Das; Hemanta Koley; Dhira Rani Saha; Sandipan Ganguly; Ranjan K Nandy; Rupak K Bhadra; Nabendu Sekhar Chatterjee
Journal:  Infect Immun       Date:  2008-09-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.